Perimenopause

• McGill University Health Centre/Research Institute of the McGill University Health Centre

  1 trialPhase 4100 people

• University of Delaware

  1 trialPhase 480 people

• University of British Columbia

  1 trialPhase 359 people

• University of North Carolina, Chapel Hill

  1 trialPhase 2/3172 people

• University of Coimbra

  1 trial150 people

• University of Alicante

  1 trial120 people

• Konya Beyhekim Training and Research Hospital

  1 trial100 people

National Institute on AgingUS$6.8mWellcome Trust£4mNational Institute of Mental HealthUS$765.6k7 grants since 2006

• Developing and Validating a Computational Phenotype for Perimenopause in Large-Scale Electronic Health Records

  National Institute of Child Health and Human DevelopmentUniversity of RochesterUS$416.1k2026–2028

• Perimenopause in Brain Aging and Alzheimer's Disease

  National Institute on AgingUniversity of ArizonaUS$5.1m2006–2031

• Development of a Nonhuman Primate Infrastructure for Interdisciplinary Research on Perimenopause and Aging

  National Institute on AgingUniversity of Tx Md Anderson Can CtrUS$629k2026–2028

• Understanding hippocampal excitatory and inhibitory circuits during perimenopause in Alzheimer's disease mice

  National Institute on AgingRosalind Franklin Univ of Medicine & SciUS$696.3k2026–2031

• Aberrant dopamine system function in a rodent model of perimenopause: relevance to psychosis

  National Institute on AgingUniversity of Texas Hlth Science CenterUS$317.2k2023–2028

• The immunobiological mechanisms of depression in perimenopause

  National Institute of Mental HealthVan Andel Research InstituteUS$765.6k2024–2029

• Mental illness in perimenopause: Longitudinal predictors and preventive treatment opportunities

  Wellcome TrustIcahn School of Medicine at Mount Sinai£4m2026–2031